In metastatic breast cancers, capecitabine is used for later lines of therapy (45), in advanced gastric cancer, in combination with platinum-based chemotherapy and/or immunotherapy and/or Her2-directed agents, depending on molecular subtypes (46). Here, ERBB2 is linked to gastric cancer.